Statin Therapy Results in the Real World Practice in the Czech Republic
STEP
1 other identifier
observational
3,253
1 country
95
Brief Summary
Statins are the first choice treatment of dyslipidemia, a major contributor to cardiovascular diseases. Statins also have enough evidence to demonstrate decrease of morbidity and mortality from cardiovascular diseases. Even though statin therapy is effective treatment of dyslipidaemia not all patients reach the goal levels. The aim of the study is to estimate proportion of patients who achieved the therapeutic goal (LDL-C. total cholesterol, HDL-C and triglycerides levels) after at least one year of a statin therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2010
Shorter than P25 for all trials
95 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2010
CompletedFirst Posted
Study publicly available on registry
January 26, 2010
CompletedStudy Start
First participant enrolled
February 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedAugust 30, 2011
August 1, 2011
4 months
January 25, 2010
August 29, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
LDL-C
one year
Secondary Outcomes (3)
Total cholesterol
one year
HDL-C
one year
triglycerides
one year
Eligibility Criteria
specialist care clinics
You may qualify if:
- Documented statin therapy for at least 12 months
- Available two LDL-C values: one at the beginning of statin therapy or at the time when patient comes to a specialist; and the other one at least after 12 months of treatment. The latter value should not be older than 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (95)
Research Site
Benešov, Czechia
Research Site
Beroun, Czechia
Research Site
Blansko, Czechia
Research Site
Bohumín, Czechia
Research Site
Boskovice, Czechia
Research Site
Brandýs nad Labem, Czechia
Research Site
Brno, Czechia
Research Site
Cheb, Czechia
Research Site
Chomutov, Czechia
Research Site
Chrudim, Czechia
Research Site
Česká Lípa, Czechia
Research Site
České Budějovice, Czechia
Research Site
Český Krumlov, Czechia
Research Site
Děčín, Czechia
Research Site
Domažlice, Czechia
Research Site
Dvůr Králové nad Labem, Czechia
Research Site
Fryštát, Czechia
Research Site
Frýdek-Místek, Czechia
Research Site
Havířov, Czechia
Research Site
Havlíčkův Brod, Czechia
Research Site
Hradec Králové, Czechia
Research Site
Hustopeče, Czechia
Research Site
Ivančice, Czechia
Research Site
Jablonec nad Nisou, Czechia
Research Site
Jeseník, Czechia
Research Site
Jičín, Czechia
Research Site
Jihlava, Czechia
Research Site
Jindřichův Hradec, Czechia
Research Site
Karlovy Vary, Czechia
Research Site
Kladno, Czechia
Research Site
Kolín, Czechia
Research Site
Krnov, Czechia
Research Site
Kuřim, Czechia
Research Site
Kutná Hora, Czechia
Research Site
Kyjov, Czechia
Research Site
Liberec, Czechia
Research Site
Litoměřice, Czechia
Research Site
Louny, Czechia
Research Site
Mělník, Czechia
Research Site
Městec Králové, Czechia
Research Site
Mikulov, Czechia
Research Site
Milevsko, Czechia
Research Site
Mladá Boleslav, Czechia
Research Site
Moravská Třebová, Czechia
Research Site
Moravské Budějovice, Czechia
Research Site
Moravský Krumlov, Czechia
Research Site
Most, Czechia
Research Site
Náchod, Czechia
Research Site
Nový Bydžov, Czechia
Research Site
Olomouc, Czechia
Research Site
Opava, Czechia
Research Site
Orlová, Czechia
Research Site
Ostrava, Czechia
Research Site
Ostrov, Czechia
Research Site
Pardubice, Czechia
Research Site
Pelhřimov, Czechia
Research Site
Pilsen, Czechia
Research Site
Písek, Czechia
Research Site
Police nad Metují, Czechia
Research Site
Polička, Czechia
Research Site
Prachatice, Czechia
Research Site
Prague, Czechia
Research Site
Prostějov, Czechia
Research Site
Přerov, Czechia
Research Site
Přeštice, Czechia
Research Site
Příbram, Czechia
Research Site
Rakovník, Czechia
Research Site
Roudnice nad Labem, Czechia
Research Site
Rožnov pod Radhoštěm, Czechia
Research Site
Rychnov nad Kněžnou, Czechia
Research Site
Semily, Czechia
Research Site
Slaný, Czechia
Research Site
Smiřice, Czechia
Research Site
Sternberk, Czechia
Research Site
Strakonice, Czechia
Research Site
Sušice, Czechia
Research Site
Svitavy, Czechia
Research Site
Tábor, Czechia
Research Site
Teplice, Czechia
Research Site
Tišnov, Czechia
Research Site
Trutnov, Czechia
Research Site
Třebíč, Czechia
Research Site
Třinec, Czechia
Research Site
Turnov, Czechia
Research Site
Uherské Hradiště, Czechia
Research Site
Ústí nad Labem, Czechia
Research Site
Valašské Klobouky, Czechia
Research Site
Veselí nad Moravou, Czechia
Research Site
Vítkovice, Czechia
Research Site
Vsetín, Czechia
Research Site
Vysoké Mýto, Czechia
Research Site
Vyškov, Czechia
Research Site
Zlín, Czechia
Research Site
Znojmo, Czechia
Research Site
Žamberk, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ales Kminek
AstraZeneca
- PRINCIPAL INVESTIGATOR
Jaromir Hradec
General faculty hospital Prague
- PRINCIPAL INVESTIGATOR
Jan Bultas
Faculty hospital Kralovske Vinohrady Prague
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2010
First Posted
January 26, 2010
Study Start
February 1, 2010
Primary Completion
June 1, 2010
Study Completion
June 1, 2010
Last Updated
August 30, 2011
Record last verified: 2011-08